Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6888 (MIR6888) is a predicted human microRNA gene encoding a short (20–24 nucleotide) non-coding RNA molecule that acts through post-transcriptional regulation of gene expression. MicroRNAs are transcribed by RNA polymerase II, processed by the RNase III enzymes Drosha and Dicer, and incorporated into the RNA-induced silencing complex (RISC), where they mediate inhibition or destabilization of target mRNAs via imperfect base pairing, with the seed region (nucleotides 2–8) being critical for target recognition[1][4][5][6]. MIR6888 is affiliated with the microRNA family; however, as of now, there is **no detailed functional, disease, or therapeutic information** available for this specific microRNA. --- - MIR6888 is a *real, annotated human microRNA gene* according to major gene resources, but its specific biological and medical significance remains unstudied or unpublished in the scientific literature as of this date[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6888 (MIR6888).